Jonathan B Orens
Overview
Explore the profile of Jonathan B Orens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keller M, Sun J, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
Transplant Direct
. 2024 Jul;
10(7):e1669.
PMID: 38953039
Background: A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study,...
2.
Keller M, Newman D, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
J Heart Lung Transplant
. 2024 May;
43(9):1374-1382.
PMID: 38705500
Background: Lung transplant recipients are traditionally monitored with pulmonary function testing (PFT) and lung biopsy to detect post-transplant complications and guide treatment. Plasma donor-derived cell free DNA (dd-cfDNA) is a...
3.
Keller M, Tian X, Jang M, Meda R, Charya A, Berry G, et al.
Am J Respir Crit Care Med
. 2024 Jan;
209(10):1238-1245.
PMID: 38190701
The association of acute cellular rejection (ACR) with chronic lung allograft dysfunction (CLAD) in lung transplant recipients has primarily been described before consensus recommendations incorporating restrictive phenotypes. Furthermore, the association...
4.
Diamond J, Anderson M, Cantu E, S Clausen E, Shashaty M, Kalman L, et al.
J Heart Lung Transplant
. 2023 Dec;
43(4):633-641.
PMID: 38065239
Background: Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Accurate prediction of PGD risk could inform donor approaches and perioperative care planning....
5.
Keller M, Tian X, Jang M, Meda R, Charya A, Ozisik D, et al.
J Heart Lung Transplant
. 2023 Nov;
43(4):563-570.
PMID: 37972825
Background: The association between organizing pneumonia (OP) after lung transplantation with the development of acute rejection (AR) remains undefined. In addition, molecular allograft injury, as measured by donor-derived cell-free DNA...
6.
Diamond J, Cantu E, Calfee C, Anderson M, S Clausen E, Shashaty M, et al.
Am J Respir Crit Care Med
. 2023 Sep;
209(1):91-100.
PMID: 37734031
Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Prior studies implicated proxy-defined donor smoking as a risk factor for PGD and mortality....
7.
Charya A, Ponor I, Cochrane A, Levine D, Philogene M, Fu Y, et al.
J Heart Lung Transplant
. 2022 Nov;
42(2):226-235.
PMID: 36319530
Background: Pulmonary antibody-mediated rejection (AMR) consensus criteria categorize AMR by diagnostic certainty. This study aims to define the clinical features and associated outcomes of these recently defined AMR categories. Methods:...
8.
Bush E, Krishnan A, Chidi A, Nolley E, Agbor-Enoh S, West N, et al.
J Heart Lung Transplant
. 2021 Dec;
41(3):300-307.
PMID: 34930671
Background: The purpose of this study was to evaluate outcomes in people with cystic fibrosis (CF) who underwent lung transplant (LT) at a transplant center with an accredited Cystic Fibrosis...
9.
Jang M, Tunc I, Berry G, Marboe C, Kong H, Keller M, et al.
J Heart Lung Transplant
. 2021 Jun;
40(8):822-830.
PMID: 34130911
Background: Acute rejection, which includes antibody-mediated rejection and acute cellular rejection, is a risk factor for lung allograft loss. Lung transplant patients often undergo surveillance transbronchial biopsies to detect and...
10.
Natalini J, Diamond J, Porteous M, Lederer D, Wille K, Weinacker A, et al.
J Heart Lung Transplant
. 2021 Feb;
40(5):351-358.
PMID: 33637413
Background: Previous studies have reported similarities in long-term outcomes following lung transplantation for connective tissue disease-associated interstitial lung disease (CTD-ILD) and idiopathic pulmonary fibrosis (IPF). However, it is unknown whether...